logo dark logoo light logo
  • 主頁
  • AM1480
  • AM1380
  • 華語電視 Sino TV
  • 聯繫我們
  • 抗疫送暖
logo dark logoo light logo
  • 主頁
  • AM1480
  • AM1380
  • 華語電視 Sino TV
  • 聯繫我們
  • 抗疫送暖
mobile logo
  • 主頁
  • AM1480
  • AM1380
  • 華語電視 Sino TV
  • 聯繫我們
  • 抗疫送暖
July 22, 2021
Uncategorized

全國日增新冠病例破15萬 輝瑞計劃每日分配760萬劑疫苗

全美週四單日新增確診病例超過15.2萬例,這是疫情爆發以來首次單日新增超過15萬例。住院治療人數週四達到67,096例,這是連續第三天刷新住院人數紀錄。

全美新冠疫情急速升溫,12日連創多個記錄,過去兩周至少有13州確診病例暴增一倍,12日單日新增確診更突破15萬例的關口,累計死亡亦超過24萬人;加州更繼德州之後,成為全美第二個新冠確診人數破100萬的州。

為了避免疫情擴散,各州陸續恢復防疫措施和居家避疫令。舊金山本週禁止餐廳內用與學校開課計劃;加州已有超過1萬8000人染疫逝世,死亡人數僅次於紐約州和德州。

截至週四,全美46州新冠新增確診呈現上升趨勢,四州保持平穩,無任何一州疫情減緩;住院人數量激增導致全國各地醫院的床位緊缺,許多人擔心無法滿足醫療需求。衛生專家警告,第三波疫情將在秋季和冬季來臨。

前幾天傳來疫苗利好消息的輝瑞公司和BioNTech 13日表示,正在建立運輸網絡,公司計劃每日運送760萬劑疫苗至附近機場。輝瑞的目標是在2020年提供1億劑疫苗,明年提供13億劑疫苗。除了密歇根州和比利時的分銷點外,輝瑞還在威斯康辛州和德國設立了額外儲存網點,以備發貨。

分享:

SHARE THIS ARTICLE

by admin
0
0
Previous post 紐約市首次推出家用檢測包 跟進市民染疫情況
Next post 秘魯新總統上任不到一週辭職 薩加斯蒂接任

即時新聞

肯州UPS貨機墜毀增至九死 料死亡人數再上升

November 5, 2025

麥當勞Q3同店銷售優預期 平價促銷支撐成長

November 5, 2025

勞動市場回溫 美10月小非農新增4.2萬超預期

November 5, 2025

成本削減撐獲利 輝瑞Q3業績優預期上修全年展望

November 4, 2025

哈佛大學醫學院爆炸案 麻州兩名男子被捕

November 4, 2025
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

CookieDurationDescription
cookielawinfo-checbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.

Performance

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

Analytics

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.

Advertisement

Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.

Others

Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.

SAVE & ACCEPT

Terms and Conditions - Privacy Policy